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Abstract
 
In severe combined immunodeficient (scid) mice, V(D)J recombination is severely impaired
due to a recessive mutation (
 
scid
 
). Thus, we were surprised to find in this study that V
 
l
 
1–J
 
l
 
1
rearrangement is routinely detectable in scid fetal liver, adult bone marrow, and spleen in the
apparent absence of completed VH–DJH and V
 
k
 
–J
 
k
 
 rearrangements. Particularly surprising,
we found the level of V
 
l
 
1–J
 
l
 
1 rearrangement in scid fetal liver to be comparable to that in fe-
tal liver of wild-type mice. The majority of scid V
 
l
 
1–J
 
l
 
1 rearrangements contained abnormal
 
deletions at the VJ junction, consistent with the known effect of 
 
scid
 
. However, 
 
z
 
15% of
V
 
l
 
1–J
 
l
 
1 rearrangements lacked abnormal deletions. Productive 
 
l
 
1 transcripts resulting from
in-frame rearrangements were readily detectable in scid adult bone marrow and spleen, consis-
tent with our ability to detect 
 
l
 
1-expressing cells by flow cytometry in the spleens of bcl-2–
transgenic scid mice. Strikingly, 
 
l
 
1 transcripts from individual scid mice often showed VJ junc-
tional sequences with the same recurring palindromic (P) additions of three, four, or five
nucleotides. To account for these findings, we suggest that (a) nonhomologous end joining of
V
 
l
 
1 and J
 
l
 
1 coding ends in fetal B lineage cells may not be (severely) impaired by 
 
scid
 
; (b) re-
curring
 
 
 
P additions in scid 
 
l
 
1 transcripts may reflect certain molecular constraints imposed by
 
scid
 
 on the resolution of V
 
l
 
1 and J
 
l
 
1 hairpin coding ends; and (c), scid lymphocytes with pro-
ductively rearranged V
 
l
 
1 and J
 
l
 
1 elements may differentiate into recombinase-inactive cells
and emigrate from bone marrow to spleen.
Key words: B cell differentiation • pro-B cells • premature Ig
 
l
 
 recombination • VJ
 
l
 
 
junctional diversity •
 
 
 
P
 
 
 
additions
 
Introduction
 
The rearrangement of Ig genes proceeds in an ordered
fashion (for review see references 1 and 2). It begins with
rearrangement of the H chain gene elements, DH and JH,
followed by VH–DJH rearrangement (3). H chain gene re-
arrangement is initiated at the pro-B cell stage and is gener-
ally followed by L chain gene rearrangement at the pre-B
cell stage (4–6), with V
 
l
 
–J
 
l
 
 rearrangement occurring later
(7–10) and/or less frequently (11–13) than V
 
k
 
–J
 
k
 
 rear-
rangement. The order of H and L chain gene rearrange-
ment is not absolute, however, as studies with B lineage
cell lines (14–16) and sorted pro-B cells (5, 6) indicate that
rearrangement at the 
 
k
 
 or 
 
l
 
 locus may precede or occur
independently of H chain gene rearrangement. Also, inac-
tivation of the 
 
k
 
 locus by gene targeting has shown that re-
arrangement of the 
 
l
 
 locus does not require prior re-
arrangement of the 
 
k
 
 locus (17, 18), consistent with
earlier  evidence for independent rearrangement of 
 
l
 
 and 
 
k
 
loci in various cell lines (16, 19–21) and in 
 
k
 
-transgenic
mice (22). Independent rearrangement of 
 
l
 
 and 
 
k
 
 loci is in
agreement with a stochastic model of L chain gene rear-
rangement (11, 23) and contrary to a strictly regulated
model of L chain gene rearrangement (for review see refer-
ence 2).
 
Consistent with the stochastic model of L chain gene re-
 
arrangement, we report here a low frequency of V
 
l
 
1–J
 
l
 
1
rearrangement in severe combined immunodeficient (scid)
 
and in wild-type (wt)
 
1
 
 mice with a targeted deletion of the
JH locus (JHT mice) (24). As JHT mice lack a functional
H chain locus, V
 
l
 
1–J
 
l
 
1 rearrangement in these mice must
occur independently of H chain rearrangement. Further-
more, as both scid and JHT mice lack pre-B cells, the ob-
served V
 
l
 
1–J
 
l
 
1 rearrangement is inferred to occur at the
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V
 
l
 
1–J
 
l
 
1 Rearrangement in Scid Mice
 
pro-B cell stage and independently of V
 
k
 
–J
 
k
 
 rearrange-
ment.
Although a low frequency of V
 
l
 
1–J
 
l
 
1 rearrangement at
the pro-B cell stage in JHT mice could have been pre-
dicted based on the stochastic model of L chain gene rear-
rangement, the regular occurrence of such rearrangement
in scid pro-B cells would not have been predicted. In scid
mice, V(D)J recombination is severely impaired as a result
of a DNA repair defect (25–27). The defect is due to a
nonsense mutation in the gene coding for the catalytic sub-
unit of DNA protein kinase (DNA-PKcs) (28–30). Because
of this mutation, developing scid lymphocytes cannot effi-
ciently join V, D, and J coding ends resulting from the ini-
tiation of V(D)J recombination (31–34). Consequently,
most developing scid lymphocytes are thought to die pre-
maturely with persisting DNA breaks. Therefore, given
that V
 
l
 
1–J
 
l
 
1 rearrangement generally follows DH–JH and
VH–DJH rearrangement and is much less frequent than
V
 
k
 
–J
 
k
 
 rearrangement, we would not expect to detect
V
 
l
 
1–J
 
l
 
1 rearrangement in scid mice.
Nonetheless, as shown here, V
 
l
 
1–J
 
l
 
1 rearrangement is
routinely detectable in fetal liver, adult bone marrow, and
spleen of individual scid mice. Moreover, in scid fetal liver
we found the level of V
 
l
 
1–J
 
l
 
1 rearrangement to be com-
parable to that in wt fetal liver. Although most scid V
 
l
 
1–
J
 
l
 
1 rearrangements showed abnormal deletions of V
 
l
 
1
and/or J
 
l
 
1 nucleotides at the VJ junction, 
 
z
 
15% lacked
abnormal deletions. Productive 
 
l
 
1 transcripts resulting
from in-frame V
 
l
 
1–J
 
l
 
1 rearrangements were clearly evi-
dent in bone marrow and spleens of individual scid mice.
Most scid 
 
l
 
1 transcripts displayed the same recurring
 
 
 
palin-
dromic (P) additions of three, four, or five nucleotides.
 
 
 
P
addition (35, 36) is thought to result from asymmetric
nicking of a hairpin coding end (37–40), followed by fill-in
of the overhang and joining to another coding end.
Our findings raise several puzzling issues: (a) Why is the
level of V
 
l
 
1–J
 
l
 
1 rearrangement comparable in fetal liver of
scid and wt mice; (b) Why do most 
 
l
 
1 transcripts of indi-
vidual scid mice show the same recurring
 
 
 
P
 
 
 
additions; and
(c) How do 
 
l
 
1 expressing scid cells survive the deleterious
effect of 
 
scid
 
 and apparently emigrate from bone marrow to
spleen? These three issues are discussed.
 
Materials and Methods
 
Mice.
 
C.B-17 mice homozygous and heterozygous for the
 
scid
 
 mutation (41) are here denoted as scid and scid/
 
1
 
 mice, re-
spectively. C.B-17 scid mice hemizygous for the bcl-2-36 trans-
gene (bcl-2 scid mice; reference 42) were obtained from S. Cory
(The Walter and Eliza Hall of Medical Research, Melbourne,
Australia). Genotyping of bcl-2 mice was done by PCR using
DNA from tail snips (43) and oligonucleotide primers for the
SV40 sequence included in the transgene (44). Mice with both of
their recombination activation gene (RAG)1 loci inactivated by
gene targeting (RAG
 
2
 
/
 
2
 
 mice; reference 45) and mice with their
JH elements deleted by gene targeting (24) were provided by R.
Hardy (Fox Chase Cancer Center). The targeted JHT allele was
backcrossed onto C.B-17 mice for three backcross generations
(N3). N3F1 mice were intercrossed to generate N3F2 mice ho-
 
mozygous for the JHT allele (JHT mice). JHT mice were crossed
with scid mice to obtain JHT/
 
1
 
, scid/
 
1
 
 mice; these were then
intercrossed to obtain JHT scid mice. Genotyping for the wt and
inactivated JH allele was done by PCR using tail DNA and prim-
ers specific for the wt and inactivated JH locus (see JH1 and JHT
oligonucleotides below). All of the above mice were bred and
maintained at the Fox Chase Cancer Center and were analyzed
between the ages of 6 and 12 wk.
 
Flow Cytometric Analysis.
 
Flow cytometry was used to test for
the presence of cells with surface Ig
 
l
 
1 (
 
l
 
1
 
1
 
 cells) in scid and bcl-2
scid mice. In brief, spleen cells of individual scid, scid/
 
1
 
, bcl-2
scid, bcl-2 scid/
 
1
 
, and RAG1
 
2
 
/
 
2
 
 mice were stained with biotin-
conjugated anti-CD8 (53.6), allophycocyanin (PharMingen)-
conjugated anti-CD45 (B220), and FITC-conjugated anti-
 
l
 
1
(R11-153–FITC; PharMingen) in the manner previously de-
scribed (46). Cells were analyzed by three-color flow cytometry
using a dual laser FACStar
 
PLUS™
 
 (Becton Dickinson). Binding of
biotinylated antibodies was revealed by Texas Red–conjugated
streptavidin (Southern Biotechnology). Dead cells were identified
by propidium iodide staining and excluded from analysis. Gates
were set to score 
 
l
 
1
 
1
 
 cells based on the distribution of l1 stain-
ing of spleen cells in the scid/1 positive controls. Due to the
paucity of l11 cells in scid and bcl-2 scid mice, between 0.5 and
1.0 3 107 spleen cells were analyzed per mouse. Cells were si-
multaneously stained for the B and T specific markers B220 and
CD8, respectively, to ensure that cells scored as l11 were indeed
B lineage cells (i.e., l11B2201CD82). Spleen cells from
RAG12/2 mice served as negative controls for background stain-
ing of l1.
Oligonucleotides. Oligonucleotides were synthesized by an Ap-
plied Biosystems 394 DNA/RNA Synthesizer. Oligonucleotides
used as primers for PCR or reverse transcriptase (RT)-PCR were as
follows: VH (#91), 59-GCCGGATCCGTGCAGCTGGTGGAG-
TCTGG-39; DH (#285), 59-ACTGCTACCTCTGGCCCCAC-
CAG-39; JH4 (#361R), 59-AGATAATCTGTCCTAAAGG-
CTC-39; Cm (#289), 59-ATGCAGATCTCTGTTTTTGCC-
TCC-39; Vk (#68), 59-GGCTGCAGGACATTGTGCTGAC-
CCAATCTCCAGCTTCT-39; Jk2 (#367), 59-GGTAGACA-
ATTATCCCTCTTCCCCTAGT-39; Ck (#130), 59-ATGGAT-
CCAGTTGGTGCAGCATC-39; Vl1ext (#282), 59-TCTCCT-
GGCTCTCAGCTCAG-39; Vl1int (#294), 59-AGGAATCTG-
CACTCACCACATC-39; Jl1 (#271), 59-GCACCTCAAGTC-
TTGGAGAG-39; Cl1 (#283), 59-GAGGAAGGTGGAAACAG-
GGTG-39;  b2ML (#229), 59-GAATGGGAAGCCGAACATAC-
TGAACTG-39; b2MR (#230), 59-TGCTGATCACATGTCTC-
GATCC-39; SV40L (#355), 59-GGAACTGATGAATGGGAGC-
AGTGG-39; SV40R (#356), 59-GCAGACACTCTATGCCT-
GTG-39; JHTL (#370), 59-CCTTGCGCAGCTGTGCTCGA-
CGTTG-39; JHTR (#371), 59-GCCGCATTGCATCAGCCAT-
GATGGA-39; JH1L (#368), 59-GGACCAGGGGGCTCAGGTC-
ACTCAGG-39; and JH1R (#369), 59-GAGGAGACGGTGAC-
CGTGGTGCCTGC-39.
Genomic PCR. z5 3 106 bone marrow or spleen cells were
used to prepare genomic DNA by PureGene Kit (Gentra Sys-
tems). PCR was carried out in 50 ml with z106 cell genome
equivalents of DNA. Controls for nonspecific amplification of
PCR products included the use of RAG2/2 DNA and no DNA
template in the reaction. Reactants included oligonucleotide
primers for DH and JH, VH and JH, Vk and Jk, Vl1 and Jl1 el-
ements or for the b2 microglobulin (b2M) locus along with 220
mM each of dATP, dGTP, dCTP, and dTTP, 0.4 mM primers,
20 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl2, and 2.5 U
of AmpliTaq DNA polymerase. The cycling reaction consisted of1935 Ruetsch et al.
an initial denaturation for 4 min at 958C, with 23 cycles of 1 min
at 948C, 45 s at 688C, and 1 min at 728C, and a final elongation
step for 5 min at 728C. 1/10 of each PCR reaction (1/20 for b2M
control) was electrophoresed through 1.5% LE agarose (FMC
Bioproducts) in 13 Tris-acetate-EDTA buffer, turboblotted by
alkaline transfer onto maximum strength Nytran Plus membranes
(Schleicher & Schuell) and hybridized in Denhardt’s solution
with the appropriate probes. Radioactive a-[32P]dCTP labeling
was done by random priming using the Prime-It II Kit (Strat-
agene). Hybridization probes included pJH6.3 (47), pECk (11),
and a PCR-amplified and gel-purified (QiaexII; Qiagen) VJl1
gene fragment to score for DH–JH (or VH–DJH), Vk–Jk, and
Vl1–Jl1 rearrangements, respectively. As a control for the
amount of input DNA, a portion of the nonrearranging b2M
gene was PCR amplified and hybridized to a b2M-specific
probe. Blots were exposed to X-Omat (Eastman Kodak Co.) au-
toradiographic film and also to a PhosphorImaging plate for
quantitation by a BAS1000Mac Bio-Imaging Analyzer (Fuji
Photo Film Co.).
RT-PCR. Total RNA from z5  3  106 bone marrow or
spleen cells was obtained by using RNEasy (Qiagen) as prescribed
by the manufacturer. RNA was eluted into DEPC-treated H2O
and stored at 2738C. RNA from the equivalent of z1.5 3 106
bone marrow cells or z3.0 3 106 spleen cells was used to synthe-
size first strand cDNA using SuperscriptII RT and 100 ng of ran-
dom hexamers (Amersham Pharmacia Biotech) as directed by the
manufacturer (GIBCO BRL). A portion of this cDNA (equiva-
lent to z3 3 105 bone marrow cells or z6 3 105 spleen cells)
was amplified by PCR using 220 mM each of dATP, dGTP,
dCTP, and dTTP, 0.4 mM primers, 20 mM Tris-HCl, pH 8.4,
50 mM KCl, 1.5 mM MgCl2, and 2.5 U of AmpliTaq DNA poly-
merase (PerkinElmer) in a reaction volume of 50 ml. Controls for
nonspecific amplification of PCR products included RAG2/2
cDNA and no cDNA template in the reaction. Semiquantitative
PCR using a PTC-100 Thermal Controller (MJ Research) was
carried out after an initial denaturation for 4 min at 958C, with 23
cycles of 1 min at 948C, 45 s at 658C, and 1 min at 728C, and a
final elongation step for 5 min at 728C. Southern blotting and
hybridization was carried out as described above. The hybridiza-
tion probes included pCm3741 (48), pECk, and gel-purified
VJl1 and b2M PCR-amplified gene fragments.
Quantitation. Conditions for semiquantitative PCR were de-
termined by varying cycle number and the amount of input
DNA (or cDNA). Filters were exposed to a Fuji imaging plate to
quantify the amount of a-32P–hybridized probe in experimental
samples relative to that in control (reference) samples using a
BAS1000Mac Bio-Imaging Analyzer (Fuji Photo Film Co.). We
found that with 23 cycles of amplification, the amount of PCR
product was proportional to the amount of input DNA (from 106
cells) at several different dilutions. Similarly, at 23 cycles, the
amount of RT-PCR product was found to be proportional to
the amount of input cDNA (from 3–6 3 105 cells) at several dif-
ferent dilutions.
Sequence Analysis. To ensure sufficient PCR product for
cloning, one microliter from the primary PCR or RT-PCR re-
action was subjected to an additional 15 cycles of PCR using
conditions as above. The Vllint primer was used with Jl1 or Cl1
for recovery of junctional sequences from genomic DNA or
cDNA, respectively. PCR products were electrophoresed
through 1.5% LE agarose, purified using QiaexII, and cloned into
pCR2.1 for transformation of INVaF9 bacteria (Invitrogen). Re-
combinant colonies were randomly chosen for plasmid recovery
by Perfect Prep (5Prime-3Prime, Inc.). Plasmids were submitted
for cycle sequencing using the ABI Prism Dye Terminator Reac-
tion Kit and an ABI 377 DNA Sequencer (PerkinElmer).
Results
Evidence for Vl1–Jl1 Rearrangement before the Pre-B cell
Stage. To test whether the l1 locus can rearrange early in
B cell differentiation, we assayed for the presence of non-
germline l1 transcripts in scid mice and also in bcl-2 scid
mice. As shown in Fig. 1 A, l1 transcripts resulting from
Vl1–Jl1 rearrangement (l1 transcripts) were clearly evi-
dent in the bone marrow of scid mice and more so in the
bone marrow of bcl-2 scid mice. The higher abundance of
l1 transcripts in the latter mice presumably reflects the
greater longevity of B lineage cells in bcl-2 scid mice than
in scid mice (42). Fig. 1 A also illustrates that transcripts re-
Figure 1. (A) Detection of l1 transcripts in bone marrow of individual
scid (s/s) and bcl-2 s/s mice and (B) in pooled bone marrow of JHT s/s
and JHT non-scid (1/1) mice. Transcripts were detected by RT-PCR
using locus-specific primers (see Materials and Methods). Transcripts cor-
responding to DH–JH, VH–DJH, Vk–Jk, and Vl1–Jl1 rearrangements
are denoted Dm, m, k, and l1, respectively. Amplification of b2M tran-
scripts served as a control for the amount of input cDNA. Results ob-
tained with wt (1/1) bone marrow are provided for comparison.1936 Vl1–Jl1 Rearrangement in Scid Mice
sulting from Vk–Jk rearrangement (k transcripts) were rou-
tinely detectable in bone marrow of bcl-2 scid but not scid
mice, whereas transcripts resulting from VH–DJH rear-
rangement (m transcripts) were barely detectable in some
bcl-2 scid mice and not at all in scid mice (Fig. 1 A). Con-
sistent with previous reports of detectable DH–JH rear-
rangement in scid mice (49, 50), Dm transcripts resulting
from DH–JH rearrangement were readily detectable in scid
and bcl-2 scid bone marrow.
As differentiation of scid B lineage cells does not gener-
ally progress beyond the pro-B cell stage, our detection of
l1 transcripts in scid mice suggests that Vl1–Jl1 rearrange-
ment may occur before the pre-B cell stage. To test
whether this is indeed true and whether the l1 locus can
rearrange independently of the H chain locus, we assayed
for l1 transcripts in bone marrow of JHT mice. In these
mice, B cell differentiation is completely arrested at the
pro-B cell stage as a result of gene-targeted inactivation of
the JH locus (24). Fig. 1 B shows that l1 transcripts were
readily detectable in JHT bone marrow. The abundance of
l1 transcripts in JHT mice was z40-fold less than in wt
mice but z25-fold greater than in JHT scid mice (Table I).
We conclude that Vl1–Jl1 rearrangement can occur at the
pro-B cell stage and independently of H chain gene rear-
rangement.
Developmental Onset of Vl1–Jl1 Rearrangement in scid and
wt Embryos. To compare the developmental onset of
Vl1–Jl1 rearrangement with that at other Ig loci, we
tested genomic DNA from pooled livers of scid and wt
embryos for DH–JH, VH–DJH, Vk–Jk, and Vl1–Jl1 re-
arrangement (Fig. 2). In wt embryos, we found that DH–
JH rearrangement could be detected as early as day 12,
whereas VH–DJH and Vk–Jk rearrangements were not de-
tectable until day 14. These results are in general agreement
with earlier reports on the time course of H and k chain
gene rearrangement in fetal mice (51, 52). In scid embryos,
DH–JH rearrangement was not clearly evident until day
14, and VH–DJH and Vk–Jk rearrangements were not de-
tected except for a VH–DJH rearrangement of aberrant size
in the day 15 sample. In contrast, Vl1–Jl1 rearrangement
was evident as early as day 12 in both scid and wt embryos.
These results indicate that Vl1–Jl1 rearrangement is initi-
ated early in development and may developmentally pre-
cede VH–DJH and Vk–Jk rearrangement.
It is important to note in Fig. 2, A and B, that the level
of Vl1–Jl1 rearrangement and l1 transcript in day 13–15
scid fetal liver remains relatively constant and appears com-
parable to that in the day 13 and 14 wt fetal liver. Indeed,
quantitation of the amount of l1 hybridizing signal for
Vl1–Jl1 rearrangement and l1 transcript in the day 13 and
14 scid samples showed this to be z80% of that in the cor-
responding wt samples (Table I). It should be noted that
the observed level of Vl1–Jl1 rearrangement in DNA
from 106 fetal liver cells was about two orders of magnitude
Table I. Level of l1 Transcripts in scid Fetal Liver and JHT scid 
Bone Marrow Relative to wt Controls
Genotype Fetal Liver Bone Marrow
1/1 1.0 1.0
s/s 1.2, 0.52 –
(0.76, 0.83) –
JHT s/s – 0.001
JHT 1/1 – 0.024
PCR-amplified (23 cycles) l1 transcripts, and also Vl1–Jl1
rearrangements in the case of fetal liver, were gel electrophoresed,
blotted, and hybridized with a l1-specific probe (see Materials and
Methods). The values shown correspond to the amount of l1
hybridizing signal normalized against the internal control (b2M) and the
reference control, fetal liver or bone marrow of wt (1/1) mice. Thus,
for example, the ratio of l1/b2M hybridizing signal in JHT (JHT 1/1)
bone marrow divided by the l1/b2M hybridizing signal in the
reference control equaled 0.024. Two values are shown for scid fetal
liver. These correspond to the ratios obtained for day 13 and 14 samples,
respectively. The two values in parentheses correspond to the ratios
obtained for Vl1–Jl1 rearrangement in genomic DNA from day 13 and
14 scid fetal liver, respectively.
Figure 2. Developmental onset of Vl1–Jl1 rearrangement relative to
that of DH–JH, VH–DJH, and Vk–Jk rearrangement in fetal liver of scid
(s) and wt (w) mice. (A) Genomic DNA from pooled fetal liver at day (d)
12, 13, 14, and 15 of gestation was subjected to PCR using locus-specific
primers to amplify DH–JH1-3, VH–DJH1-4, Vk–Jk1,2, and Vl1–Jl1
rearrangements. Amplification of the nonrearranging b2M gene served as
a control for input DNA. (B) Amplification of l1 and b2M transcripts
was done by RT-PCR.1937 Ruetsch et al.
less than in control DNA samples from 106 adult bone mar-
row cells of wt mice (data not shown). This is not surpris-
ing, as day 13–14 fetal liver lacks detectable pre-B cells and
contains #1% pro-B cells (reference 53 and our unpub-
lished results).
Vl1–Jl1 Rearrangements from scid Mice Contain Abnormal
Deletions at the VJ Junction. PCR-amplified Vl1–Jl1 re-
arrangements were detectable not only in scid fetal liver
and adult bone marrow, but also in scid adult spleen. In
most of these rearrangements, the Vl1 and/or Jl1 coding
segments were abnormally truncated by .20 nucleotides.
Deletions of this magnitude were not observed in Vl1–Jl1
rearrangements from wt mice. Representative results are il-
lustrated in Figs. 3 and 4 for adult bone marrow and spleen,
respectively. More than 70% of scid Vl1–Jl1 rearrange-
ments (121/147 distinct sequences analyzed) contained ab-
normal deletions; those lacking such deletions often
showed unusually long P additions, as illustrated in Fig. 4.
Vl1–Jl1 rearrangements from bone marrow of JHT
mice, in contrast to those from bone marrow of scid mice,
showed nontemplated (N) additions and comparatively
small deletions at the VJ junction (Fig. 3). N addition is de-
pendent on terminal deoxynucleotidyl transferase (TdT)
(54, 55). This enzyme is expressed at the pro-B cell stage
(56), the stage at which B cell differentiation is arrested in
JHT mice (24). The absence of N additions in Vl1–Jl1
junctions from wt mice (Figs. 3 and 4) is in agreement with
earlier reports (57, 58) and consistent with the occurrence
of most L chain rearrangement at the late pre-B cell stage
(5, 6), when TdT expression is dramatically downregulated
(56). As scid and JHT mice both show an arrest of B cell
differentiation at the pro-B stage, the abnormal loss of nu-
cleotides in scid Vl1–Jl1 junctions must reflect the effect
of the scid mutation and not a peculiarity of premature
Vl1–Jl1 rearrangement.
l1 Transcripts in scid Adult Bone Marrow and Spleen Lack
Abnormal Deletions at Their VJ Junction. Most l1 transcripts
from scid adult bone marrow and spleen corresponded
to in-frame Vl1–Jl1 rearrangements with frequent P ad-
ditions (illustrated in Fig. 5). The P additions consisted
of three to five nucleotides (cag, ccag, and gaaat) and
were found repeatedly in individual mice. The most com-
mon recurring sequence consisted of two  P additions
separated by an AT dinucleotide (gaaat-AT-ccag). Interest-
ingly, the AT dinucleotide is palindromic to the last two
nucleotides of the (gaaat) P addition. Similar restricted VJ
junctional sequences and recurring P additions were also
observed in l1 transcripts recovered from bcl-2 scid spleen
(data not shown). It is important to note that each PCR
amplification of bone marrow and splenic cDNA from scid
mice was done in parallel with PCR amplification of
splenic cDNA from wt and RAG12/2 mice. We found
Figure 3. Representative Vl1–Jl1 junctional sequences in genomic
DNA from pooled fetal liver (FL) of scid (s/s) embryos (day 13) and from
pooled bone marrow (BM) of s/s, wt (1/1), and JHT adult mice. Germ-
line nucleotides (nt) for the 39 and 59 ends of the Vl1 and Jl1 gene are
shown at the top (the germline Vl1 and Jl1 coding regions comprise 297
and 38 nt, respectively). Upper- and lowercase letters under the N/P col-
umn denote N and P nucleotide additions, respectively. The number of
V or J nucleotides deleted from the Vl1 or Jl1 coding end is indicated in
parentheses; the asterisk denotes an in-frame rearrangement.
Figure 4. Representative Vl1–Jl1 junctional sequences in genomic
DNA of pooled spleen (SPL) from scid (s/s) and wt (1/1) adult mice.
Format is as in Fig. 3.1938 Vl1–Jl1 Rearrangement in Scid Mice
that l1 transcripts from three individual wt mice lacked
N/P additions (illustrated in Fig. 5). No l1 transcripts were
recovered from cDNA of RAG12/2 mice. Thus, the ob-
served recurring P additions appear to be a unique property
of l1 transcripts in the bone marrow and spleens of scid
mice.
We analyzed a total of 188 cloned sequences from l1
transcripts in bone marrow and/or spleens of five individ-
ual scid mice. We found that 115 clones contained P addi-
tions. In Fig. 6, each distinct junctional sequence (denoted
A–I) among the 115 clones is listed according to its repre-
sentation in individual mice and overall frequency (see his-
togram). Sequences B and C are treated as one in the histo-
gram, as are sequences F and G, because each of these pairs
is identical except for the substitution of T (underlined) for
C in the Vl1 germline codon, AGC. Note that (a) se-
quences A–G, comprising most of the clones (110/115),
corresponded to in-frame Vl1–Jl1 rearrangements; (b) se-
quences A, B, and C accounted for z70% (83/115) of the
Vl1–Jl1 rearrangements; and (c), the gaaat-AT-ccag P ad-
dition was present in all mice analyzed and represented
nearly 40% of the clones (45/115).
In contrast to scid mice, l1 transcripts from JHT scid
mice lacked P additions and showed abnormal deletions at
their VJ junctions similar to scid genomic Vl1–Jl1 rear-
rangements; furthermore, most corresponded to out-of-
frame Vl1–Jl1 rearrangements (illustrated in Fig. 5). These
results suggest, as discussed later, that survival of l1-express-
ing scid cells could depend on the coexpression of a Dm
(or m) chain. Consistent with this possibility, Dm and l1
transcripts were the only Ig gene transcripts routinely
detectable in scid bone marrow (illustrated in Fig. 1).
Moreover, most scid Dm transcripts (10/16 analyzed) cor-
responded to DH–JH rearrangements in reading frame 2
(data not shown), which would be expected to result in the
expression of a Dm chain.
Cell Surface Expression of l1 Chains Is Detectable in Spleens
of bcl-2 scid Mice. The presence of l1-expressing scid cells
in the spleen prompted us to test for possible cell surface
expression of l1 chains (l11 cells) in the spleens of scid and
bcl-2 scid mice. The latter mice were included because sur-
vival of scid B lineage cells is known to be enhanced in the
presence of the bcl-2 transgene (42). Large numbers (5–10 3
106) of cells were analyzed by three-color flow cytome-
try for expression of cell surface l1 and the B and T cell
markers CD45 (B220) and CD8, respectively. Mice with
an inactivated RAG1 locus (RAG12/2 mice; reference 45)
served as a negative control for background staining of
l1. As illustrated in Fig. 7, there were no detectable
l11B2201CD82 cells in scid and RAG12/2 mice. How-
ever, in bcl-2 scid mice, l11B2201CD82 cells were de-
tectable at a frequency of 0.02–0.05% versus 0.5–1.5% in
Figure 5. Representative VJ junctional sequences in l1 transcripts
from individual scid (s/s), wt (1/1), and JHT scid mice. Both bone mar-
row (BM) and spleen (SPL) of three s/s and three 1/1 mice was ana-
lyzed; the results for two individuals are shown. Format is as in Fig. 3.
Figure 6. Recurring P additions in VJ junctions of l1 transcripts from
scid adult mice. Bone marrow and/or spleens of five individual scid mice
were analyzed. We obtained VJ junctional sequences from 188 clones and
found that 115 of these contained P additions. 9 distinct VJ junctional se-
quences were found among the 115 clones; these are denoted (A–I) be-
low the underlined germline sequence for the Vl1 and Jl1 coding ends.
The number of mice that contained a given VJ junctional sequence is in-
dicated at left. The asterisk denotes that the rearrangements were in
frame. The overall frequency of each distinct junctional sequence (A–I) is
shown in the histogram.1939 Ruetsch et al.
the wt controls. The distribution of B220 staining for l1
gated cells is shown in the histograms on the right side of
Fig. 7. Note that bcl-2 scid spleen cells stained less bright
for B220 and l1 than scid/1 or bcl-2 scid/1 spleen cells.
These results indicate that a low frequency of scid cells ex-
press l1 chains on their cell surfaces and can be detected in
the spleen of bcl-2 scid mice.
Three-color flow cytometry was used also to analyze
bcl-2 scid mice for expression of surface m chains (m1
cells). No m1 cells were detected (data not shown), consis-
tent with previous reports showing a lack of m1 cells in
bcl-2 scid spleen (42, 59).
Discussion
The preceding results support earlier evidence, cited in
the Introduction, that initiation of rearrangement at the l
locus does not require prior rearrangement at the H or k
chain locus. Our detection of l1 transcripts in bone mar-
row of scid and JHT mice indicates that Vl1–Jl1 rear-
rangement can occur before the pre-B cell stage and inde-
pendently of H chain gene rearrangement. Moreover, the
detection of Vl1–Jl1 rearrangement as early as day 12 in
wt fetal liver, in which there is no genetic impairment of Ig
gene rearrangement, suggests that the onset of Vl1–Jl1 re-
arrangement may developmentally precede VH–DJH and
Vk–Jk rearrangement. The latter rearrangements were not
detectable before day 14.
The most novel aspect of our findings is the regular de-
tection of Vl1–Jl1 rearrangement in scid mice. This
would not have been predicted, particularly the compara-
ble level of Vl1–Jl1 rearrangement in scid and wt fetal
liver. Also unexpected are the recurring P additions in scid
l1 transcripts and the presence of scid cells with in-frame
Figure 7. Detection of l1-expressing cells in spleens of bcl-2 scid (s/s) mice by three-color flow cytometry. Gate settings for scoring l11 cells in bcl-2
s/s mice were based on the distribution of l1 staining in positive and negative controls, bcl-2 s/1 and RAG2/2 mice, respectively. l11 cells in bcl-2 s/s
and s/1 control mice are denoted in the shaded areas of the histograms for relative cell number versus l1 staining. The l11 cells in the shaded areas were
analyzed for CD8 and B220 expression; most of these cells (.85%) displayed a B cell phenotype (l11B2201CD82) and fell within the boxed areas. The
l11 cells in bcl-2 s/s mice represented z0.02–0.05% of the spleen cells analyzed and showed a l1dullB220dull phenotype. In contrast, l11 cells in s/1 and
bcl-2 s/1 mice were l1brightB220bright and represented z0.5–1.5% of the spleen cells analyzed. The overlay of B220 histograms on the far right shows the
distribution of B220 staining for cells in the s/s and RAG2/2 mice and for l11 cells in the bcl-2 s/s, s/1, and bcl-2 s/1 mice.1940 Vl1–Jl1 Rearrangement in Scid Mice
Vl1–Jl1 rearrangements in the spleen. We discuss the im-
plications of these findings below.
Levels of Vl1–Jl1 Rearrangement and l1 Transcript in scid
Mice. We were surprised to find that the level of Vl1–
Jl1 rearrangement in scid fetal liver was comparable to that
in wt fetal liver (Table I), despite the abnormal loss of nu-
cleotides in the VJ junction of most scid Vl1–Jl1 rear-
rangements. Thus, in scid fetal liver, abnormally truncated
Vl1 and Jl1 coding ends appear to be joined as efficiently
as Vl1 and Jl1 coding ends in wt fetal liver. This is unex-
pected because previous studies have clearly shown that
V(D)J rearrangement is severely impaired in B and T lin-
eage cells of adult scid mice (31–34). Indeed, as discussed
below, Vl1–Jl1 rearrangement in scid adult bone marrow
cells appears to be much less efficient than in wt bone mar-
row cells. The basis for the comparable level of Vl1–Jl1
rearrangement in scid and wt fetal liver is unexplained.
Possibly, the machinery available for nonhomologous end
joining in fetal liver differs from that in adult bone marrow
and is able to compensate for the scid deficiency in DNA-
PKcs.
Whereas the level of l1 transcripts was comparable in
scid and wt fetal liver, in scid adult bone marrow (from
JHT scid mice), l1 transcript levels were z25-fold less
than in control adult bone marrow of JHT mice (Table I).
The latter comparison is valid because B cell differentiation
is arrested at the same stage (pro-B cell stage) in both JHT
and JHT scid mice. Moreover, neither JHT nor JHT scid
mice can make Dm or m chains, which could potentially af-
fect the selection (or survival) of cells with productive l1
transcripts.
Two explanations can be considered for the 25-fold dif-
ference in levels of l1 transcript in JHT and JHT scid adult
bone marrow. The first postulates that the scid l1 tran-
scripts are much less stable than those generated in wt bone
marrow, possibly owing to the abnormal nucleotide dele-
tions accompanying scid Vl1–Jl1 rearrangement. We
would expect such instability to be manifest in scid fetal
liver as well, and yet in this tissue the level of l1 transcript
was comparable to that in wt fetal liver. A second explana-
tion is that the 25-fold difference in abundance of l1 tran-
scripts in JHT and JHT scid mice primarily reflects a lower
efficiency of Vl1–Jl1 rearrangement in scid adult pro-B
cells than wt adult pro-B cells. This explanation is consis-
tent with previous studies showing a 10–20-fold lower
level of DH–JH rearrangement in scid than in wt adult
bone marrow (49, 50).
The question arises as to why we did not obtain evi-
dence of premature Vk–Jk rearrangement in scid bone
marrow, given that a low level of such rearrangement has
been previously observed in the pro-B cell fraction of wt
mice (5, 6). One possible reason is that initiation of Vk–Jk
rearrangement invariably results in cell death. Consistent
with this possibility, k transcripts were readily detectable in
the bone marrow of bcl-2 scid mice. The bcl-2 transgene is
known to promote the longevity of scid B lineage cells (42)
and their differentiation beyond the pro-B cell stage (42,
59). As reasoned elsewhere (60), primary and secondary
initiation of Vk–Jk rearrangement in scid cells lacking the
bcl-2 transgene would be expected to result in persisting
chromosomal breaks and cell death.
VJ Junctions of scid l1 Transcripts Show Recurring P Addi-
tions. Most l1 transcripts recovered from scid adult mice
corresponded to in-frame Vl1–Jl1 rearrangements, and
.60% of these transcripts contained recurring P additions.
Whereas in wt mice most P additions are one or two nu-
cleotides (61), in scid mice they are often longer (62, 63).
In the present case, all of the scid P additions at Vl1 were
five nucleotides in length (gaaat), and those at Jl1 were ei-
ther three or four nucleotides in length (cag or ccag). This
may reflect a strong bias in the resolution of hairpin coding
ends imposed by the scid DNA-PKcs deficiency, such that
Jl1 and Vl1 coding ends are frequently nicked three to
four and five nucleotides from the hairpin tip, respectively,
and then joined without further modification. In addition,
cells expressing l1 transcripts with these junctions may be
strongly selected, as discussed later.
Of particular interest is the recurring Vl1–Jl1 junctional
sequence of two P additions separated by an AT dinucle-
otide (gaaat-AT-ccag), which was present in z40% of the
l1 transcripts with P additions (Fig. 6). The basis for the
AT dinucleotide is unclear. Given that scid Vl1–Jl1 rear-
rangements occur at the pro-B cell stage in the presence of
high TdT levels, the AT dinucleotide could represent a
nontemplated addition mediated by TdT. Another possi-
bility is that the AT dinucleotide, which is palindromic to
the last two nucleotides of the gaaat P addition, corre-
sponds to a secondary  P addition. In this scenario, one
could postulate two successive recombination events. The
generation of the gaaat P addition would result from an
open and shut recombination (64) at Vl1. This would be
followed by secondary cleavage at the Vl1 signal/coding
border, asymmetric nicking of the Vl1 hairpin coding end,
and joining to a Jl1 coding end with a ccag overhang. Re-
gardless of how the AT dinucleotide is generated, we sug-
gest that cells with the gaaat-AT-ccag junctional sequence
are strongly selected to account for the repeated occurrence
of this sequence in l1 transcripts of individual scid mice.
Evidence for l1-Expressing scid Cells. Scid  l1 transcripts
were not only detected in bone marrow but also in spleen.
Moreover, l1 transcripts with the same VJ junctional se-
quences were often found to recur in both of these tissues.
This implies a strong selection for cells with in-frame Vl1–
Jl1 rearrangements containing particular VJ junctional se-
quences. Such selection was not evident in JHT scid mice.
l1 transcripts from JHT scid bone marrow contained ab-
normal deletions at the VJ junction, lacked P additions, and
in most cases corresponded to out-of-frame Vl1–Jl1 rear-
rangements. These findings suggest that survival and selec-
tion of l1-expressing cells requires a functional H chain
locus.
How might l1-expressing scid cells be dependent on a
functional H chain locus? One possibility is that Dm and l1
chains, resulting from expression of in-frame Dm and l1
transcripts in scid bone marrow, pair and associate with the
Ig a and b signal-transducing chains (65, 66) to form a B1941 Ruetsch et al.
cell–like receptor (BCRDm/l1). Although Dm chains can-
not pair efficiently with k chains (67), they can pair with
the surrogate L chain (68, 69) and might be expected to
pair with l1 chains as well because the latter share some
homology with the surrogate L chain (for review see refer-
ence 70). Expression of BCRDm/l1 in this proposed sce-
nario would signal rapid (or direct) progression of scid pro-B
cells to the recombinase-inactive B cell stage and allow
these cells to survive and migrate to the periphery. But as
BCRDm/l1 would lack a VH region, we would not ex-
pect cells bearing this receptor to persist or expand in re-
sponse to naturally occurring antigens. This could in part
explain the very low frequency of cells with surface l1 in
bcl-2 scid spleen (#0.05% of the cells examined). What is
experimentally missing in support of the above scenario,
however, is evidence for bcl-2 scid cells with surface l1
and m chains. Despite reported evidence for intracellular
expression of m (or Dm) chains in B2201CD221 spleen
cells of bcl-2 scid mice (59), cells with surface m chains
have not been detected in bcl-2 scid mice (42, 59).
In conclusion, we suggest that (a) joining of Vl1 and Jl1
coding ends after the initiation of Vl1–Jl1 rearrangement
may not be impaired in B lineage cells of scid fetal liver be-
cause of the developmental time at which such rearrange-
ment occurs; (b) recurring P additions in scid l1 transcripts
may reflect a strong bias in the resolution of Vl1 and Jl1
hairpin coding ends imposed by the scid defect as well as
possible strong selection for cells expressing these l1 tran-
scripts; and (c) pro-B cells with in-frame Vl1–Jl1 rear-
rangements may express a pre-BCR–like receptor and dif-
ferentiate into recombinase-inactive cells and emigrate
from bone marrow to spleen.
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